Application of Membrane Separation and Concentration Technology in Heparin Sodium Extraction

Heparin sodium is a critical natural anticoagulant polysaccharide mainly extracted from porcine intestinal mucosa. Traditional purification processes relying on centrifugation, plate-and-frame filtration and resin adsorption face obvious drawbacks: high solvent consumption, low product yield, heavy wastewater discharge and unstable quality. Membrane separation and concentration technology has become an efficient green alternative for heparin sodium production.

The integrated membrane workflow usually consists of microfiltration, ultrafiltration and nanofiltration with diafiltration. Ceramic microfiltration first removes solid residues, denatured proteins and coarse impurities from the enzymatic hydrolysate, clarifying the feed liquid and protecting subsequent membrane and resin units. After clarification, spiral-wound ultrafiltration intercepts heparin molecules while removing small molecular impurities, pigments and partial heteroproteins. The following nanofiltration and diafiltration steps realize desalination and concentration, cutting the dosage of ethanol for alcohol precipitation and lowering production cost.

Compared with conventional methods, the membrane process operates at ambient temperature, avoiding thermal degradation of active heparin components. It supports continuous or batch operation and can be flexibly scaled up from lab and pilot test rigs to full industrial production lines. The closed pipeline design also reduces microbial contamination risk and improves batch consistency.

Nevertheless, membrane fouling remains the main challenge. Regular CIP cleaning and reasonable control of cross-flow velocity and TMP are essential to stabilize long-term running. With proper membrane selection and process optimization, membrane separation greatly improves heparin recovery rate, reduces carbon footprint and brings remarkable economic and environmental benefits for heparin manufacturers.